-
Comparing the Social and Private Value Created by Pembrolizumab 2014-2022
Mar 10, 2025, 14:00 PM -
Exploring Mobile and Wearable Technology for Early Depression Detection and Monitoring
Mar 10, 2025, 14:00 PM -
Payer Survey Uncovers Likely Increased Management Strategies Following Release of Initial 10 Drugs Selected for Price Negotiation
Mar 10, 2025, 14:00 PM -
Impact of Disability on Burden of Illness Among Patients With Chronic Inflammatory Demyelinating Polyneuropathy in the United States
Mar 10, 2025, 14:00 PM -
Early Signals of Inflation Reduction Act Impact on Pharmaceutical Investment and Prioritization Decisions
Mar 10, 2025, 14:00 PM -
Analysis of the Effect of Trofinetide Treatment on the Domain and Item-Level Responses of the Rett Syndrome Behavior Questionnaire Using Data From the LAVENDER Trial
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness Analysis of Olaparib and Niraparib With Abiraterone Versus Abiraterone for First-Line Treatment of BRCA Mutated Metastatic Castration-Resistant Prostate Cancer in Taiwan
Mar 10, 2025, 14:00 PM -
Estimating the Potential Cost-Effectiveness of Long-Acting Naltrexone versus Oral Naltrexone for Alcohol Use Disorder
Mar 10, 2025, 14:00 PM -
Real-World Clinical Outcomes, Healthcare Resource Utilization, and Direct Medical Costs in Atrial Fibrillation Patients Receiving Catheter Ablation in Japan
Mar 10, 2025, 14:00 PM -
Consumer and Healthcare Provided Preferences for Adult Combination COVID-19 and Influenza Vaccines: Results from a Discrete Choice Study in France, Italy and Germany
Mar 10, 2025, 14:00 PM -
Linkage of Clinical Trial Data to Real-World Data (RWD) Sources: A Scoping Review
Mar 10, 2025, 14:00 PM -
Real-World Adverse Event Profile of Glucagon-Like Peptide-1 Receptor Agonists in Overweight and Obese US Adults
Mar 10, 2025, 14:00 PM -
An Open-Source R-Shiny Application Designed to Perform Frequentist and Bayesian Mixed Model Repeated Measures (MMRM)
Mar 10, 2025, 14:00 PM -
The Efficacy of Panitumumab Plus Chemotherapy As Initial Treatment for KRAS Wild-Type Unresectable, Metastatic Colorectal Cancer: A GRADE-Approach Systematic Review and Meta-Analysis
Mar 10, 2025, 14:00 PM -
Acute Myocardial Infarction and Associated Healthcare Resource Utilization and Costs Among U.S. Patients With Extreme High Versus Low Lipoprotein (a)
Mar 10, 2025, 14:00 PM -
Psychometric Validation and Meaningful Within-Patient Change of the FAACT-5IASS in Patients With Cancer Cachexia
Mar 10, 2025, 14:00 PM -
Economic and Healthcare Impacts of Public Funding for Intermittent Catheters in Nova Scotia
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness of Follitropin Delta versus Follitropin Alfa in Controlled Ovarian Stimulation for IVF/ICSI Cycles in China
Mar 10, 2025, 14:00 PM -
Estimating the Magnitude of a Pull Incentive for Antibiotic Development Using the STEDI Value Framework: An Example From Spain
Mar 10, 2025, 14:00 PM -
Healthcare Resource Utilization Among Ticagrelor-Treated Patients With Bleeding or Undergoing Urgent Surgery in the United States: A Real-World, Retrospective Claims Analysis
Mar 10, 2025, 14:00 PM